CVS Health Corp.
CVS | NYSE
$88.44
-$1.81 (-2.01%)
Nov 2, 2026, 12:18 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 106.1B | 100.43B | 105.69B | 102.87B | 98.92B | 94.59B | 97.71B | 95.43B | 91.23B | 88.44B | 93.81B | 89.76B | 88.92B | 85.28B | 83.85B | 81.16B | 80.64B | 76.83B | 76.6B | 73.79B | 72.62B | 69.1B |
Cost of Revenue | 90.35B | 84.8B | 92.13B | 89.07B | 85.32B | 80.19B | 84.81B | 82.87B | 77.85B | 75.88B | 79.94B | 76.19B | 75.32B | 71.9B | 70.03B | 67.77B | 66.78B | 63.43B | 62.95B | 61.09B | 59.42B | 56.6B |
Gross Profit | 15.75B | 15.62B | 13.57B | 13.81B | 13.59B | 14.4B | 12.9B | 12.56B | 13.38B | 12.56B | 13.88B | 13.58B | 13.6B | 13.38B | 13.81B | 13.39B | 13.86B | 13.39B | 13.65B | 12.7B | 13.2B | 12.5B |
Operating Income | 4.7B | 4.68B | 2.11B | -3.21B | 2.38B | 3.37B | 2.37B | 832M | 3.05B | 2.27B | 3.37B | 3.69B | 3.23B | 3.45B | 3.62B | -3.92B | 4.67B | 3.55B | 2.23B | 3.06B | 4.33B | 3.58B |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 3.98B | 3.94B | 1.35B | -3.48B | 1.65B | 2.62B | 2.13B | 105M | 2.34B | 1.58B | 2.71B | 3.02B | 2.57B | 2.88B | 3.11B | -4.44B | 4.13B | 3B | 1.57B | 2.15B | 3.74B | 2.97B |
Net Income | 3B | 2.94B | 2.94B | -3.98B | 1.02B | 1.78B | 1.64B | 87M | 1.77B | 1.11B | 2.05B | 2.26B | 1.9B | 2.14B | 2.3B | -3.41B | 3.03B | 2.35B | 1.31B | 1.6B | 2.78B | 2.22B |
Selling & General & Admin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 11.05B | 10.94B | 11.46B | 17.01B | 11.21B | 11.02B | 10.53B | 11.73B | 10.34B | 10.29B | 10.5B | 9.89B | 10.37B | 9.93B | 10.2B | 17.31B | 9.19B | 9.85B | 11.42B | 9.64B | 8.87B | 8.92B |
Operating Expenses | 11.05B | 10.94B | 11.46B | 17.01B | 11.21B | 11.02B | 10.53B | 11.73B | 10.34B | 10.29B | 10.5B | 9.89B | 10.37B | 9.93B | 10.2B | 17.31B | 9.19B | 9.85B | 11.42B | 9.64B | 8.87B | 8.92B |
Interest Expense | 757M | 774M | 787M | 784M | 763M | 785M | 758M | 752M | 732M | 716M | 690M | 693M | 686M | 589M | 552M | 566M | 583M | 586M | 608M | 602M | 636M | 657M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 101.39B | 95.75B | 103.58B | 106.08B | 96.53B | 91.21B | 95.34B | 94.6B | 88.19B | 86.17B | 90.44B | 86.07B | 85.69B | 81.83B | 80.23B | 85.08B | 75.97B | 73.28B | 74.38B | 70.73B | 68.29B | 65.52B |
Income Tax Expense | 982M | 995M | -1.57B | 508M | 634M | 835M | 503M | 34M | 569M | 456M | 658M | 754M | 656M | 737M | 809M | -1.05B | 1.09B | 646M | 274M | 558M | 944M | 746M |
Shares Outstanding (Basic) | 1.28B | 1.27B | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.26B | 1.29B | 1.29B | 1.28B | 1.28B | 1.31B | 1.32B | 1.31B | 1.31B | 1.32B | 1.32B | 1.32B | 1.31B |
Shares Outstanding (Diluted) | 1.28B | 1.28B | 1.28B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B | 1.27B | 1.29B | 1.29B | 1.29B | 1.29B | 1.32B | 1.32B | 1.32B | 1.33B | 1.34B | 1.33B | 1.33B | 1.32B |
EPS (Basic) | 2.33 | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 | 0.07 | 1.41 | 0.88 | 1.59 | 1.76 | 1.48 | 1.66 | 1.78 | -2.59 | 2.31 | 1.79 | 0.99 | 1.21 | 2.11 | 1.69 |
EPS (Diluted) | 2.31 | 2.30 | 2.30 | -3.13 | 0.80 | 1.41 | 1.30 | 0.07 | 1.41 | 0.88 | 1.59 | 1.75 | 1.48 | 1.65 | 1.77 | -2.59 | 2.29 | 1.77 | 0.98 | 1.20 | 2.10 | 1.68 |
EBITDA | 4.73B | 5.83B | 3.29B | -1.56B | 3.58B | 4.56B | 4.03B | 2.02B | 4.22B | 3.43B | 4.53B | 4.84B | 4.36B | 4.47B | 4.71B | -2.83B | 5.79B | 4.64B | 3.29B | 3.88B | 5.51B | 4.75B |
EBIT | 4.73B | 4.71B | 2.14B | -2.7B | 2.41B | 3.4B | 2.88B | 857M | 3.07B | 2.3B | 3.4B | 3.71B | 3.26B | 3.47B | 3.66B | -3.88B | 4.71B | 3.59B | 2.18B | 2.75B | 4.37B | 3.63B |
Depreciation & Amortization | n/a | 1.12B | 1.15B | 1.13B | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B | 1.14B | 1.13B | 1.13B | 1.1B | 1B | 1.05B | 1.05B | 1.08B | 1.05B | 1.12B | 1.13B | 1.14B | 1.13B |
Add to Watchlist
Select watchlists to add or remove CVS